Skip to main content
Premium Trial:

Request an Annual Quote

GNS Healthcare to Help Develop Predictive Models for Multiple Sclerosis, Other Diseases

Premium

GNS Healthcare said this week that it will help develop a predictive model for multiple sclerosis and other diseases under the umbrella of Orion Bionetworks, a newly minted non-profit alliance that aims to use computational modeling to study disease mechanisms in order to select and develop more effective treatments.

The company said that it will use clinical, biomarker, and imaging data from 7,000 patients provided by members of the alliance to build a computational model for multiple sclerosis that could provide new information about the mechanisms of disease and also help physicians select better treatments for their patients.

Besides GNS Healthcare, other participants in the multiple sclerosis project include Accelerated Cure Project for Multiple Sclerosis, the Institute for Neurosciences at Brigham and Women's Hospital, MetaCell, and PatientsLikeMe.

The alliance is initially focusing on models for MS,but members also plan to study other diseases.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.